Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06111365 · ClinicalTrials.gov registry record
Pivotal Observational CHLOE Study
A clinical trial of IVF, sponsored by Fairtility.
- Completed
- Registry status
- 59
- Enrollment target
- 3
- Study locations
NCT06111365: Completed study of IVF, sponsored by Fairtility.
NCT06111365 is a study of IVF that has completed, run by Fairtility. The registered enrollment target is 59 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06111365, a study of IVF, has completed, sponsored by Fairtility.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 3
- Study locations
Study Summary
This pivotal study is an observational, prospective assessment, multi-center, databank based, clinical study aimed to evaluate the performance of CHLOE™ algorithm in prediction of blastocyst formation.
Primary Outcome
The prediction of blastocyst outcome using CHLOE algorithm, and the actual blastocyst outcome for a subset of good/fair embryos will be measured using odds ratio.
Conditions Studied
Interventions
- DEVICE CHLOE
Study Locations (3)
New York
- Weill Cornell Medicine - New York
Ohio
- Cleveland Clinic Fertility - Cleveland
Texas
- Dallas Fertility Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2024-08-12 |
What the finished NCT06111365 record still lists
NCT06111365 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 1 condition, with IVF appearing as the primary indexed condition, and to 1 intervention - of which CHLOE is the first listed.
NCT06111365 reports a single indexed study location in New York, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT06111365 about?
NCT06111365 is a clinical study titled "Pivotal Observational CHLOE Study". This pivotal study is an observational, prospective assessment, multi-center, databank based, clinical study aimed to evaluate the performance of CHLOE™ algorithm in prediction of blastocyst formation.
What is the current status of trial NCT06111365?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2024-01-22. Estimated completion is 2024-08-12.
What conditions does trial NCT06111365 study?
This clinical trial studies the following conditions: IVF.
What interventions are being tested in trial NCT06111365?
The interventions under investigation include: CHLOE (DEVICE).
Who is sponsoring clinical trial NCT06111365?
This trial is sponsored by Fairtility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06111365 being conducted?
This trial has 3 study locations across New York, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for IVF
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI